Alyssa Hemmen
Physician Assistant · Marietta, GANPI 1053802595
Payments from drug & device makers
Across 322 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$920
- AbbVie$869
- AstraZeneca$752
- Pfizer$585
- Lilly USA, LLC$551
- GSK$453
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,83499%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $920 |
| AbbVie | 47 | $869 |
| AstraZeneca | 35 | $752 |
| Pfizer | 27 | $585 |
| Lilly USA, LLC | 33 | $551 |
| GSK | 26 | $453 |
| Axsome Therapeutics, Inc. | 11 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $200 |
| Johnson & Johnson(2 entities) | 7 | $144 |
| Sumitomo Pharma America, Inc. | 7 | $121 |
| Exact Sciences | 7 | $121 |
| Abbott | 6 | $118 |
| Bayer | 5 | $111 |
| Astellas Pharma US Inc | 2 | $103 |
| Optinose US, Inc. | 5 | $100 |
| Novartis | 3 | $99 |
| Esperion Therapeutics, Inc. | 5 | $82 |
| Merck | 4 | $62 |
| Actelion Pharmaceuticals US, Inc. | 2 | $42 |
| Amgen | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
| Scynexis, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$5,903 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $17,360 |
| Rosuvastatin Calcium | 15 | $275 |
| Losartan Potassium | 17 | $188 |
| Amlodipine Besylate | 18 | $94 |
| Atorvastatin Calcium | 12 | $92 |
| Levothyroxine Sodium | 18 | $73 |
| Lisinopril | 20 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $920 | $17,36011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Marietta
- Lisa HillMarietta$190K
- Annmarie ZuardoMarietta$25K
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.